课题基金 / 基金详情

ROLE OF INTRAFOLLICULAR ACTIVIN AND FOLLISTATIN IN PCOS

ROLE OF INTRAFOLLICULAR ACTIVIN AND FOLLISTATIN IN PCOS
卵泡内激活素和卵泡抑素在 PCOS 中的作用
批准号:
6429999
负责人:
ALAN L SCHNEYER
金额:
$23.61万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-12-01 至 2002-06-30

项目摘要

项目成果

ALAN L SCHNEYER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The broad goal of this project is to investigate the critical autocrine/paracrine role of the inhibin/activin/follistatin system in normal human follicular development and in women with Polycystic Ovary Syndrome (PCOS). To address the underlying defects leading to the classic PCOS ovarian appearance of numerous peripherally arranged, small follicles, we hypothesize that an excess of bioavailable activin contributes to both increased follicular development as well as developmental arrest of maturing follicles. Our approach is to obtain transvaginal follicular aspirates from well-characterized normal or PCOS volunteers, which can then be used to document the progression from an activin-B dominant to an inhibin-A dominant microenvironment suggested by previous immunohistochemical approaches. Specifically, we propose: Specific Aim 1: To delineate the role of the intrafollicular inhibin/activin/follistatin axis in the autocrine/paracrine regulation of normal folliculogenesis and ovulation in the human. Specific Aim 2. To characterize defects in inhibin/activin subunit biosynthesis, processing or dimerization in the abnormal follicular maturation observed in PCOS. Specific Aim 3. To determine the role of intrafollicular follistatin in regulating activin activity, and thereby follicular growth, in women with PCOS. Specific Aim 4. To determine the mechanism whereby FS regulates activin action at the cell surface in human granulosa cells and related cell line models. Thus, this Project strives to provide key information to facilitate the transition from bench (Specific Aim 4) to bedside (Specific Aims 2 and 3) while also providing a valuable normative database (Specific Aim 1) for analysis of PCOS and other studies of ovarian pathophysiology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development Of Novel Diabetes Therapies Based On Neutralizing FSTL3 Activity
  • 批准号:
    9389587
  • 项目类别:
  • 资助金额:
    $19.21万
  • 财政年份:
    2016
  • 负责人:
    ALAN L SCHNEYER
  • 依托单位:
Regulation Of Follicle Development and Fertility By Activin and Follistatin
Physiologic Roles of Activin and Myostatin Antagonists
Regulation Of Follicle Development and Fertility By Activin and Follistatin
海外基金